Rs1989754

Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.